1990
DOI: 10.1101/gad.4.6.978
|View full text |Cite
|
Sign up to set email alerts
|

A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B.

Abstract: As a first step toward defining the elements necessary for g immunoglobulin gene regulation, DNase I hypersensitive sites were mapped in the mouse X locus. A hypersensitive site found 15.5 kb downstream of CX4 was present in all the B-cell but not in the T-cell lines tested. This site coincided with a strong B-cell-specific transcriptional enhancer (E~24). This novel enhancer is active in myeloma cells, regardless of the status of endogenous X genes, but is inactive in a T-cell line and in fibroblasts. The enh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
68
0

Year Published

1991
1991
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(71 citation statements)
references
References 80 publications
3
68
0
Order By: Relevance
“…We speculate that the reason for the differential requirement of PU.1 and/or Spi-B for the Ig vs the Ig and IgH genes might be the nature of the enhancers present in these loci. The Ig locus contains two enhancers that are nearly identical, and are believed to have arisen by gene duplication (57). Both of these enhancers contain PU.1-IRF-4 composite binding sites and therefore the cumulative effect of loss of PU.1 and/or Spi-B activity may be significant impairment of enhancer function (26).…”
Section: Discussionmentioning
confidence: 99%
“…We speculate that the reason for the differential requirement of PU.1 and/or Spi-B for the Ig vs the Ig and IgH genes might be the nature of the enhancers present in these loci. The Ig locus contains two enhancers that are nearly identical, and are believed to have arisen by gene duplication (57). Both of these enhancers contain PU.1-IRF-4 composite binding sites and therefore the cumulative effect of loss of PU.1 and/or Spi-B activity may be significant impairment of enhancer function (26).…”
Section: Discussionmentioning
confidence: 99%
“…Ig light-chain gene transcription and recombination are dependent on the activity of several enhancer elements (Hagman et al 1990;Gorman et al 1996;Xu et al 1996;Inlay et al 2002). The locus has two distinct enhancers (Ei and E3Ј ), whereas the locus has two duplicated enhancers (E 2-4, E 3-1).…”
Section: Irf-48 −/− Pre-b Cells Are Impaired For Light-chain Gene Trmentioning
confidence: 99%
“…Subsequently, one-third of the transfected cells were cultured at the permissive temperature, and the remaining two-thirds were incubated at the nonpermissive temperature for 22 h. Firefly and Renilla luciferase activities were measured in protein extracts (25 g) with a dual assay kit (Promega). The pV and pVE constructs contain the V2 promoter alone (14) or together with E2-4 (14) in the BamHI site of the pGL2 basic plasmid (Promega). The 6xB plasmid contains six B binding sites located upstream of a minimal thymidine kinase promoter in pGL2-basic plasmid (18).…”
Section: Reporter Gene Assaysmentioning
confidence: 99%
“…Two nearly identical Ig enhancers (E3-1 and E2-4), which are active in mature B and plasma cells, require binding by the PU.1/IFN regulatory factor-4 transcription factor complex (13). Importantly, E3-1 and E2-4 function in an NF-B-independent manner in these late-stage cells (14).…”
mentioning
confidence: 99%